Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Planet Fitness faces securities fraud probe after 31% stock plunge due to failed marketing shift

Market News
01 Jul 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Planet Fitness is under investigation for potential securities fraud after its stock dropped 31% on May 7, 2026, following disappointing Q1 membership growth and lowered revenue guidance. The company shifted its marketing focus from casual gym-goers to more fitness-minded members, which alienated its core audience and hurt growth. The law firm Bleichmar Fonti & Auld LLP is investigating whether Planet Fitness misled investors about the success of this marketing strategy. Investors who suffered losses are encouraged to contact the firm for possible legal action.

More News

Deadlines set for lead plaintiff appointments in class action lawsuits against BitGo, ADMA Biologics, and Erasca.

Deadlines set for lead plaintiff appointments in class action lawsuits against BitGo, ADMA Biologics, and Erasca.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...

Market News
Bearish
56 minutes ago
Ocular Therapeutix to present new retinal disease data at July 2026 scientific and investor conferences

Ocular Therapeutix to present new retinal disease data at July 2026 scientific and investor conferences

Ocular Therapeutix announced its participation in multiple scientific and investor conferences in July 2026, including presentations on its investigational retinal drug AXPAXLI and real-world data on anti-VEGF treatments. Key events include the OIS R...

Others
Neutral
56 minutes ago
Step Pharma appoints Neil Gallagher as Non-Executive Director to boost cancer drug development.

Step Pharma appoints Neil Gallagher as Non-Executive Director to boost cancer drug development.

Step Pharma has appointed Neil J. Gallagher, MD, PhD, as a Non-Executive Director to strengthen its board as it advances dencatistat, a first-in-class CTPS1 inhibitor targeting essential thrombocythaemia, lymphoma, and solid tumours. Gallagher brings...

Company Fundamentals
Bullish
56 minutes ago
Gaming and Leisure Properties sets Q2 2026 earnings release for July 30 with a conference call on July 31.

Gaming and Leisure Properties sets Q2 2026 earnings release for July 30 with a conference call on July 31.

Gaming and Leisure Properties, Inc. announced it will release its second quarter 2026 financial results after market close on July 30, 2026. The company will hold a conference call on July 31, 2026, at 10:00 a.m. ET to discuss the results and recent ...

Company Fundamentals
Neutral
56 minutes ago
GlobalFoundries schedules Q2 2026 earnings call for August 5, 2026

GlobalFoundries schedules Q2 2026 earnings call for August 5, 2026

GlobalFoundries announced it will hold a conference call on August 5, 2026, at 8:30 a.m. ET to discuss its second quarter 2026 financial results. Investors and interested parties can join the call by registering online, and the webcast will be availa...

Company Fundamentals
Neutral
56 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App